3.8 Article

Fatigue in Rheumatoid Arthritis Patients: Association With Sleep Quality, Mood Status, and Disease Activity

期刊

REUMATOLOGIA CLINICA
卷 16, 期 5, 页码 339-344

出版社

ELSEVIER ESPANA SLU
DOI: 10.1016/j.reuma.2018.07.010

关键词

Depression; Disease activity; Fatigue; Rheumatoid arthritis; Sleep disturbance

向作者/读者索取更多资源

Objectives: Rheumatoid arthritis (RA) is a chronic inflammatory disease, characterized by polyarthritis and systemic manifestations. RA-fatigue is a significant problem and adds on disease burden. Sleep disturbance, depression, and disease activity are suggested contributing factors to RA-fatigue; however, their combined role did not examine before among Egyptian RA patients. The objective of the study was to investigate the presence of fatigue, sleep and mood disturbances in RA patients. Also, to evaluate the possible association of poor sleep, depression, and disease activity with RA-fatigue. Methods: This cross-sectional study included 115 RA patients diagnosed according to the 2010 ACR-EULAR criteria and 46 age and sex matched controls. Fatigue using the Multidimensional Assessment of Fatigue-Global Fatigue Index, sleep using the Pittsburgh Sleep Quality Index and mood status using Beck Depression Inventory were assessed for all participants. RA disease activity was evaluated using disease activity score-28 joints. Results: RA patients had higher mean fatigue, sleep disturbance, and depression scores (27.2 +/- 8.9, 6.4 +/- 3.6, and 12.8 +/- 7.3; respectively) than controls (22.7 +/- 7, 4.8 +/- 3, 7.8 +/- 5.9; respectively) (P < .05). Poor sleep, depression and higher disease activity were significantly correlated with fatigue (r = 0.4, r = 0.65, r = 0.55; respectively) (P < .001). The three variables may explain up to 49.1% of the variation in fatigue on multiple regression analysis. Conclusion: Fatigue, poor sleep, and depression are more common in Egyptian patients with RA. A remarkably higher fatigue was associated with poor sleep, depression, and high disease activity, thus monitoring these silent comorbidities in clinical practice is required. (C) 2018 Elsevier Espana, S.L.U. and Sociedad Espanola de Reumatologia y Colegio Mexicano de Reumatologia. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

3.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据